MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--Following a series of productive meetings last week, biotech innovator Rainbow Coral Corp. (OTCBB: RBCC) targeted an emerging leader in the field of regenerative medicine for addition to its growing partner portfolio.
“This current potential target is on the cutting edge of adult stem cell treatments and regenerative medicine biotechnologies,” said RBCC CEO Kimberly Palmer. “They are devising new treatment options with tremendous market potential, making them an ideal candidate for our participation.”
RBCC’s highly successful recent meetings were the latest in a series of aggressive moves to seek out and cultivate additional industry partnerships with companies involved in regenerative medicine and biotechnology. RBCC partners and representatives have also appeared at numerous industry conventions, attracting potential clients as it continues its development of game-changing medical technologies.
“We’ve seen some great progress in our search for high-level investment and partnership opportunities,” Palmer said. “Our recent positive talks in Texas offer significant growth potential both for the companies involved, and our shareholders and investors.”
RBCC is dedicated to delivering advanced medical research and technologies to a booming global health marketplace, predicted to be worth $224 billion by 2017. For more information on RBCC’s initiatives, please visit www.rainbowbiosciences.com.
About Rainbow Biosciences
Rainbow Biosciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp. (OTCBB: RBCC). The Company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit www.RainbowBioSciences.com. For investment information and performance data on the Company, please visit www.RainbowBioSciences.com/investors.html.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
